Akero Therapeutics, Inc. (AKRO)

54.65 0.00 (0.00%) USD  |  NASDAQ  |  Dec 17, 16:00
More

Akero Therapeutics Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for AKRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Eli Lilly & Co. Upgrade
Bristol Myers Squibb Co. Upgrade
Johnson & Johnson Upgrade
Adaptive Biotechnologies Corp. Upgrade